Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/19/2866376/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.biopharmadive.com/news/ultragenyx-angelman-gtx-102-interim-results/713169/
https://www.globenewswire.com/news-release/2024/04/12/2862138/20739/en/Ultragenyx-Announces-Upcoming-Data-Presentations-at-American-Academy-of-Neurology-AAN-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/22/2851131/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/02/27/2836492/20739/en/Ultragenyx-to-Participate-at-Investor-Conferences-in-March.html
https://www.globenewswire.com//news-release/2024/02/23/2834646/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/02/15/2830348/20739/en/Ultragenyx-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/08/2826418/20739/en/Ultragenyx-to-Host-Conference-Call-for-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Update.html
https://endpts.com/ultragenyx-boosts-case-for-new-surrogate-biomarker-in-snapshot-of-rare-disease-data/
https://www.globenewswire.com//news-release/2024/02/06/2824223/20739/en/Ultragenyx-Announces-Data-Demonstrating-Treatment-with-UX111-Results-in-Significant-Reduction-in-Heparan-Sulfate-Exposure-in-Cerebrospinal-Fluid-Correlated-with-Improved-Long-term-.html